EC
EcoR1 Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123M | Hold |
4,288,120
| – | – | 7.3% | 5 |
|
|
2025
Q1 | $144M | Hold |
4,288,120
| – | – | 8.53% | 5 |
|
|
2024
Q4 | $219M | Hold |
4,288,120
| – | – | 8.29% | 3 |
|
|
2024
Q3 | $219M | Buy |
4,288,120
+132,745
| +3% | +$6.78M | 7.5% | 3 |
|
|
2024
Q2 | $186M | Hold |
4,155,375
| – | – | 5.69% | 5 |
|
|
2024
Q1 | $195M | Buy |
4,155,375
+2,142,858
| +106% | +$100M | 4.92% | 5 |
|
|
2023
Q4 | $71.6M | Buy |
2,012,517
+482,254
| +32% | +$17.2M | 1.86% | 15 |
|
|
2023
Q3 | $45.5M | Buy |
1,530,263
+200,000
| +15% | +$5.95M | 1.54% | 15 |
|
|
2023
Q2 | $24M | Hold |
1,330,263
| – | – | 0.59% | 24 |
|
|
2023
Q1 | $21.4M | Hold |
1,330,263
| – | – | 0.69% | 25 |
|
|
2022
Q4 | $24.3M | Hold |
1,330,263
| – | – | 0.74% | 26 |
|
|
2022
Q3 | $26.1M | Hold |
1,330,263
| – | – | 0.77% | 27 |
|
|
2022
Q2 | $24.8M | Buy |
1,330,263
+540,054
| +68% | +$10.1M | 0.86% | 26 |
|
|
2022
Q1 | $17.3M | Buy |
790,209
+200,040
| +34% | +$4.39M | 0.54% | 36 |
|
|
2021
Q4 | $16.8M | Buy |
+590,169
| New | +$16.8M | 0.53% | 29 |
|
|
2020
Q3 | – | Sell |
-859,802
| Closed | -$15.1M | – | 46 |
|
|
2020
Q2 | $15.1M | Buy |
859,802
+509,802
| +146% | +$8.93M | 1.11% | 25 |
|
|
2020
Q1 | $5.15M | Buy |
+350,000
| New | +$5.15M | 0.54% | 33 |
|